The report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
Download
PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Browse
- 150 Market Data Tables
- 65 Figures
- 350 Pages and in-depth TOC on " Hemodialysis
and Peritoneal Dialysis Market - Global Forecast to 2029”
Some of the prominent key players are:
- Fresenius Medical Care AG & Co. KGaA
(Germany),
- Baxter International Inc. (US),
- Nipro Corporation (Japan),
- NIKKISO CO., LTD. (Japan), and many
more......
Mergers & acquisitions, investments & expansions,
partnerships & collaborations, and new product developments are some of the
major strategies adopted by these key players to enhance their positions in the
Hemodialysis and Peritoneal Dialysis Market .
Growth
Driver: Rising prevalence of chronic kidney disease globally
The rising prevalence of chronic kidney disease
(CKD) globally is expected to significantly drive the hemodialysis and
peritoneal dialysis market. Chronic kidney disease is likely to affect more
than 10% of the population worldwide as chronic kidney disease becomes more
prevalent due to factors such as aging populations, increasing rates of
diabetes and hypertension, increasing the CKD progression to end-stage renal
diseases, necessitating the dialysis. Chronic kidney disease (CKD) is more
prevalent among individuals aged 65 years or older. According to Centres of
Disease Control and Prevention (CDC), an estimated 35.5 million people in US
were diagnosed with CKD in 2023.
Opportunity:
High growth potential of emerging markets
Emerging markets such as China, India, Brazil, are
expected to offer significant growth opportunities for players operating in the
POC diagnostics market. This is primarily due to the high and growing
prevalence of diabetes, chronic kidney diseases, in these countries. As
economic growth in China and India continues to expand, there is rise in
healthcare spending across these countries, which leads to improved
affordability of hemodialysis and peritoneal dialysis treatment. According to
the article published by BMC Nephrology in 2023, in China, the prevalence of
ESRD is projected to reach 1,505 patients per million population by 2025. To
meet the increasing demand for dialysis in the emerging markets, players focus
on acquiring or entering into agreements and partnerships with healthcare
providers.
Market Segmentation:-
- The hemodialysis market is segmented
based on product and service. Hemodialysis products include hemodialysis
machines and hemodialysis consumables & supplies, whereas hemodialysis
services include in-center services and home services. The hemodialysis
services segment is anticipated to grow at significant rate during the
forecast period.
- Based on end users, home care setting is
expected to grow at a significant rate owing to growing preference of
patients for home hemodialysis modality, technological advancements, and
the cost-effectiveness of home dialysis treatment over incentre dialysis
procedures.
- On the basis of region, the hemodialysis
and peritoneal dialysis market is segmented into North America, Europe,
Asia Pacific, and the Latin America, Middle East & Africa. The
Asia-Pacific market is likely to witness significant market growth. This is
attributed to the rise in geriatric patient population, increasing cases
of chronic kidney diseases, moreover improving healthcare infrastructure
and the implementation of supportive government initiatives to increase
the accessibility of dialysis services in many APAC countries such as
India and China.
Recent
Developments of Hemodialysis and Peritoneal Dialysis Industry:
- In July 2023, Rockwell Medical
acquired the hemodialysis concentrates business from Evoqua Water
Technologies, strengthening its presence in the hemodialysis market
- In January 2022, Nextkidney BV
acquired Dialyss Pte Ltd, enhancing its technology capabilities in home
hemodialysis
- In March 2021, DaVita Inc. signed
an agreement with Fresenius Medical Care AG & Co. KGaA for the
expansion of the usage of NxStage Home Hemodialysis Machines
The escalating global prevalence of chronic
kidney disease, spurred by growing aging population coupled with the increasing
cases of diabetes and hypertension are fuelling the demand for renal
replacement therapy including hemodialysis and peritoneal dialysis products and
services. Ongoing technological advancements in dialysis technology, growing
patient preference of home dialysis, supporting reimbursement policies and
government initiatives and funding for healthcare infrastructure, enabling
expansion of hospitals and dialysis centers further enhancing the accessibility
of hemodialysis and peritoneal dialysis services among patients with end-stage
renal disease (ESRD) are likely to drive the market growth during the forecast
period.
No comments:
Post a Comment